Beyza KARADEDE UNAL

Dr. Beyza KARADEDE UNAL

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Science Progress
Verified
Journal Article
Open access
PDF file
BUBeyza KARADEDE UNAL
Beyza KARADEDE UNAL
DDDeniz Dellaloğlu
Deniz Dellaloğlu
Objective: It is aimed to examine the tooth sizes of digital models of patients with different malocclusions with the help of three-dimensional measurement software. Methods: Digital models of 252 patients aged between 13 and 25 years of age were included. According to the Angle classification, three different malocclusion groups were allocated such that there were 84 patients in each group, plaster models of patients scanned with the three-dimensional model browser 3Shape R700 3D Scanner (3Shape A/S Copenhagen, Denmark) and transferred to the digital format. 3Shape Ortho Analyzer (3Shape A/S Copenhagen, Denmark) software was used for making the necessary tooth size measurements. Results: When the measurements were evaluated, it was determined that significant changes occurred between tooth sizes of individuals with different malocclusions. Generally, higher values were observed in mesiodistal and buccolingual tooth dimensions of class II individuals compared to other groups. There was no difference between the groups in the anterior ratio values, but when the overall ratio values were evaluated among the groups, a statistically significant difference was determined. Class II malocclusion group was found to have a significantly lower overall ratio of occurrence. Conclusion: Individuals with different malocclusions differ in tooth size.

11 March 2021 in Turkish Journal of Orthodontics
Verified
Journal Article
Closed access
BUBeyza KARADEDE UNAL
Beyza KARADEDE UNAL
İHİsmail Hamit Hancı
İsmail Hamit Hancı
EAEmre Aytuğar
Emre Aytuğar
FEFerhan Elmalı
Ferhan Elmalı
BKBerşan Karadede
Berşan Karadede
MKMehmet Irfan Karadede
Mehmet Irfan Karadede
Age,chin,forensic dentistry,gender

19 August 2020 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
BABurçin AKAN
Burçin AKAN
GKGokcenur Gokce Kara
Gokcenur Gokce Kara
BUBeyza KARADEDE UNAL
Beyza KARADEDE UNAL
TETürkan Sezen Erhamza
Türkan Sezen Erhamza

1 March 2024 in The Angle Orthodontist
Verified
Journal Article
Open access
PDF file
RNRafael Ecija Navarro
Rafael Ecija Navarro
BKBerşan Karadede
Berşan Karadede
BUBeyza KARADEDE UNAL
Beyza KARADEDE UNAL
DSDomingo Martin Salvador
Domingo Martin Salvador
Objectives: To evaluate the influence of facial biotype in the therapeutic effect of mandibular advancement devices (MADs) according to polysomnographic records in patients diagnosed with sleep apnea–hypopnea syndrome (SAHS). Materials and Methods: A total of 46 patients were recruited. Patients were classified according to facial biotype (mesofacial, brachyfacial, or dolichofacial). The quantitative variables were described as the arithmetic mean and standard deviation or the median and interquartile range. Hypothesis tests used were Pearson’s chi-square, paired-sample Student’s t - test, the Wilcoxon test, one-way analysis of variance, Kruskal-Wallis test, and Mann-Whitney U -test. P < .05 was considered statistically significant. Results: A total of 46 patients were categorized into three facial biotype subgroups with no significant differences among them in age, body mass index, neck circumference, and sex. The respiratory disturbance index (RDI) results were as follows: brachyfacial patients had a reduction to 15 events/h ( P < .001), the mesofacial patients had a reduction to 14 events/h ( P < .001), and the dolichofacial patients did not show a significant reduction. The oxygen desaturation index (ODI) results were as follows: brachyfacial patients had a reduction in ODI episodes to 45 episodes/h ( P = .001), mesofacial patients had a reduction to 18 episodes/h ( P = .001). In the brachyfacial group, the number of awakenings with MAD therapy was reduced to 23 events/h ( P = .003), while, in the mesofacial group, it was reduced to 37 episodes/h ( P = .012). Conclusions: The facial biotype influences the effectiveness of MAD therapy and is considered a good predictive factor.

30 April 2021 in Makara Journal of Health Research
Verified
Journal Article
Open access
PDF file
BUBeyza KARADEDE UNAL
Beyza KARADEDE UNAL
Background: This study aimed to examine the effects of ectodermal dysplasia (ED) on the transverse width of the maxillary bone. Methods: The ED group was composed of seven people, while the control group consisted of retrospective cone-beam computed tomography images of seven individuals with skeletal class 1 relationship. Images on the sagittal planes were taken, and cross-sections were taken from the longest point of the Anterior Nasal Spine-Posterior Nasal Spine line. The distance between the distal anterior canine teeth from the right buccal cortical bone to the left buccal cortical bone was measured. At the posterior region, the distance between the right point where the pterygoid protrusions and the tuber maxilla fused and the left point was measured. Results: The ED group has significantly narrower (p < 0.05) anterior region than the control group, and no significant difference in the posterior region width was found between the ED group and control group. Conclusions: The quality of life should be improved by awareness of ED in dentistry, by using a professional approach and modern applications such as three-dimensional computed tomography when necessary, and by considering the morphological characteristics of the patients.

29 September 2021 in Research Square
Verified
Preprint
Open access
PDF file
RNRafael Ecija Navarro
Rafael Ecija Navarro
BKBerşan Karadede
Berşan Karadede
BUBeyza KARADEDE UNAL
Beyza KARADEDE UNAL
DSDomingo Martin Salvador
Domingo Martin Salvador
Background: In the scientific literature, there is no consistency of results regarding the effectiveness of mandibular advancement devices (MADs) for sleep apnoea treatment. We have considered facial growth as an important predictor of treatment. In this study we analysed that how facial biotype can influence the therapeutic effect of MADs according to polysomnographic records in SAHS patients.Methods: The study enrolled 46 patients with mild to moderate SAHS diagnosed by a polysomnographic test. Using cephalometry, we classified all the patients according their facial biotype (mesofacial, brachyfacial or dolichofacial). Shapiro-Wilk test was used to choose the parametric or non-parametric tests. The quantitative variables were described with the arithmetic mean with its standard deviation or the median with its interquartile range. The hypothesis tests used were Pearson’s chi-squared test, paired sample Student's t test, the Wilcoxon test, one-way ANOVA, Kruskal-Wallis test and Mann-Whitney U test. A p < 0.05 was considered statistically significant.Results: The respiratory disturbance index (RDI) results were: brachyfacial patients had a reduction to 15 events/hour (p < 0.001), the mesofacial patients had a reduction to 14 events/hour (p < 0.001) and the dolichofacial patients did not show a significant reduction in the RDI. The oxygen desaturation index (ODI) results were as follows: brachyfacial patients had a reduction in ODI episodes to 45 episodes/hour (p = 0.001), mesofacial patients had a reduction to 18 episodes/hour (p = 0.001). The dolichofacial patients did not show a reduction in this index. As far as the number of arousals, in the brachyfacial group, the number of awakenings with MAD therapy was reduced to 23 events/hour (p = 0.003), while in the mesofacial group, it was reduced to 37 episodes/hour (p = 0.012). The same behaviour was observed in the dolichofacial group, did not have a reduction in the number of awakenings during sleep after MAD therapy.Conclusions: The facial biotype influences the effectiveness of MAD therapy and is considered a good predictive factor. Dolichofacial patients failed to obtain a significant result in the polysomnographic records using a MAD for sleep apnoea treatment.